Stepping up minority recruiting (ricans make up at least 12 percent of th...)

Stepping up minority recruiting

Date:6/3/2009

ricans make up at least 12 percent of this country's population, they and other emerging majorities are clearly underrepresented in medicine and the health professions," said DeLa Cadena. "Their representation as scientists is even more scant."

Between 2001 and 2005, the School of Medicine ran a similar program the Short-Term Summer Research Program which trained 70 underrepresented students in the health professions. But in 2005 the NIH changed the initiative to promote diversity in research activities, and it's taken DeLa Cadenda three years of fine-tuning to satisfy the NIH's new funding requirements.

"It was so frustrating not to have been able to offer something over the past three years," said DeLa Cadena, "especially when we've witnessed the success we've had with students who took the previous short-term summer program."

Ann Igbre was one of the 70 Temple students who participated in the summer program in 2004. She calls the experience "wonderful."

"The program introduced me to research and really helped me understand the importance of research in medicine," said Igbre. "That summer, I was able to put together a simple research question, test it and see the results. Plus, having that experience on my resume was great when applying for residency."

Now in the ophthalmology residency program at Temple, Igbre is studying racial differences in diabetic retinopathy. She credits the summer program for making her a competitive applicant and is glad to hear that more minority students like her will get opportunities through STEP UP.

The STEP UP grant comes with few strings. The research must be within the scope of areas of interest to the National Heart, Lung and Blood Institute (NHLBI). This requirement places the Cardiovascular Center, the Lung Center and the Thrombosis Research Center in an ideal position to train a future cohort of health professional scientists.

"I strongly believe physician sci
'/>"/>

Contact: Megan Chiplock
chiplock@temple.edu
215-707-1731
Temple University
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Stepping Up: D.C. Wards 7 and 8 Teens to Teach Prevention of HIV, Obesity in Summer Youth Program
2. SEIU Members Stepping up Their Efforts for Obama-Biden Ticket
3. Annie Lennox Is Stepping Up and Singing Out in the 2008 Sing Campaign Against HIV/AIDS in South Africa and Around the World
4. Florida Health Care Community Stepping Up for the 2007-2008 Flu Season
5. AMA Foundation Names Minority Scholars Award Recipients
6. Report Reveals Disparities in Pharmaceutical Treatment for Minority Patients
7. Michigan Blues CEO Daniel J. Loepp Reinforces Companys Commitment to Minority Business Partners
8. American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health
9. National Minority Quality Forum Provides Tracking Tool to Address Cardiovascular Disease in Minority Populations
10. Heart Transplant Failures More Likely in Poor, Minority Kids
11. Health Disparities Among Minority Populations Getting Worse

Post Your Comments:

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Industry in the U.S. and its ... ,, http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The ... Industry report provides the latest market ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, ... - Market Forecasts to 2015, Competitive ... ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

(Date:12/15/2009)... Aon Consulting, the global human capital consulting ... AON ), today announced Lisa Zeitel has ... with the Health & Benefits Practice and ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO ) ,, ... under the direction of Aon Consulting,s Pharmacy ...

(Date:12/15/2009)... Dec. 15 Hospira, Inc. (NYSE: ... in generic injectable pharmaceuticals, and Orchid Chemicals ... a leading Indian pharmaceuticals company and among ... today announced an agreement for Hospira to ... business for approximately $400 million. ,, ...

(Date:12/15/2009)... acid synthesis in brain cancer cells may offer a ... glioblastomas that are driven by amplified signaling of the ... study by researchers at UCLA,s Jonsson Comprehensive Cancer Center. ... the formation of new membranes. The fatty acids also ... and may be important for regulating cell signaling, said ...

[0] Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] Targeting brain cancer cell metabolism may provide new treatment

... Champion,SAN FRANCISCO, May 13 Brown & Toland Physicians ... award Lisa Marie Harrison of San Ramon the inaugural ... Bay Area woman who has made dramatic improvements to ... time weighed 235 pounds and smoked heavily. After a ...

... to be Implemented Across Slovenia LJUBLJANA, Slovenia, May 13 ... that it will roll out a new electronic health ... IBM ) technology across the country.(Logo: ... healthcare providers to instantly and accurately check a patient,s ...

... report suggests , , WEDNESDAY, May 13 (HealthDay News) -- ... least one bout of major depression in the past ... received treatment, a new government report released Wednesday shows. ... Services Administration (SAMHSA), the report found that health insurance ...

... that looked at obituary photographs published in one metropolitan newspaper ... appearance, particularly for women. , The study found that the ... younger age than when he or she died more than ... than twice as likely as men to have an obituary ...

... Enables Pulmonx to Develop Both Assessment Tools and ... 13 Pulmonx, a medical device company focused ... today that it has acquired all of the ... (EBV) technology platform and associated intellectual property. Pulmonx ...

... Pregnant women and newborns are at greatest risk ... done to ensure that they receive priority treatment should ... Medical Center (UPMC) and University of Pittsburgh study. The ... , raise concerns about the ability of hospitals to ...

Other Medicine News:Health News:IBM Helps Government of Slovenia to Build Smart Health Insurance System 2 Health News:IBM Helps Government of Slovenia to Build Smart Health Insurance System 3 Health News:Most Depressed Teens Don't Get Treatment 2 Health News:Obituary photos suggest growing bias against aging faces 2 Health News:Obituary photos suggest growing bias against aging faces 3 Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 2 Health News:Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting 3 Health News:Influenza pandemic planning needed to assure adequate care for pregnant women and newborns 2

From Heart Attack Scare to Half-Marathon IBM Helps Government of Slovenia to Build Smart Health Insurance System Most Depressed Teens Don't Get Treatment Obituary photos suggest growing bias against aging faces Pulmonx Acquires Assets of Emphasys Medical and Unveils Combined Product Portfolio at International Conference of the American Thoracic Society (ATS) Annual Meeting Influenza pandemic planning needed to assure adequate care for pregnant women and newborns

(Date:12/15/2009)... ,, Reportlinker.com announces that a ... its catalogue: ,, Hepatitis B Vaccines ... 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, ... Market Forecasts to 2015 ,, Summary ... new report, "Hepatitis B Vaccines - Pipeline ...

(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, Boehringer Ingelheim GmbH: ... ,, Introduction ,, This analysis ... Boehringer Ingelheim in the Rx pharmaceutical sector. ... pipeline analysis and assessment of financial performance, ...

(Date:12/15/2009)... 15 Waters Corporation (NYSE: ... (v.7.1 SR4), an electronic laboratory notebook solution for ... secure electronic repository that stores and manages all ... and is used to boost efficiency in life ... SAFE-BioPharma digital identity and signature standard. The SAFE-BioPharma ...

Breaking Medicine Technology:Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6 Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6 Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5 Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6 China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 1 China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 2 China Yongxin Pharmaceuticals Inc to Distribute Medicines on the Essential Drug List 14997 3 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 1 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 2 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 3 FDA Grants Orphan Drug Designation for 3 4 DAP for LEMS 14995 4 Facial Injectables Emerge From the Recession 6587 1 Facial Injectables Emerge From the Recession 6587 2 Facial Injectables Emerge From the Recession 6587 3

[0] Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 [0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile [0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard

... ASCO Showed Acceptable Tolerability Profile, ... Low Incidence of Grade 3 and 4 Neuropathy, ... eribulin mesylate (E7389) demonstrated activity in a,heavily pretreated population ... to results of a multi-center Phase II clinical,trial. The ...

... N.J., May 15 Sanofi-aventis,(EURONEXT: SAN and ... the,landmark ATHENA study showed Multaq(R) (dronedarone), a ... atrial fibrillation or atrial flutter,decreased the risk ... by a statistically significant 24% (p=0.00000002), meeting ...

Other Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2 Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6 Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7

Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation

Super High Density, multi-frequency, convex array, small footprint transducer for scanning during craniotomies....

This unique tiny transducer can be very helpful in tight situations like during a carotid endardarectomy procedure....

... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...

... Hemispheric Sound Technology, multi-frequency, linear ... transducer is very helpful in ... to be a choice transducer ... scanning. Its high frequency upper ...

Medicine Products:

Multi Frequency Neuro Convex Transducer UST-987.7.5 Multi Frequency Micro Surgery Transducer UST-5531 Multi Frequency Flexible Laparoscopic Transducer UST-5536-7.5 Multi frequency Micro Surgery Transducer UST-533

Stepping up minority recruiting(ricans make up at least 12 percent of th...),Health